Biosci Trends March 2020 PMID 32037389

Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.

Zhenwei Wang, Xiaorong Chen, Yunfei Lu, Feifei Chen, Wei Zhang

Mentions

15
Peak: 6 in Feb 2020
across 3 sources since Feb 2020

Extended reach

24,269
potential audience

Total likes

37

Video views

3,930

Mentions per month

Feb 2020 – Jan 2021

Where it's discussed

  • X / Twitter9 posts
  • YouTube4 videos
  • Blogs2 articles

AI synopsis

What people are saying

Several discussions highlight the combination of Chinese and Western medicine as a promising approach, mentioning specific treatments like SFJDC and lopinavir/ritonavir, with words like 'appears to have some activity' and 'case series' indicating cautious optimism and interest in clinical outcomes. The overall tone reflects curiosity and recognition of potential therapeutic value, though with acknowledgment that more research is still needed.

AgreementModerate agreement

Most discussions acknowledge the potential benefits of combining Chinese and Western treatments, though some remark that further research is needed, indicating cautious support.

InterestModerate interest

The posts demonstrate moderate interest by highlighting the novelty of combining traditional and modern medicine approaches to COVID-19 treatment.

EngagementModerate engagement

Comments include referencing specific medicines like SFJDC and antiviral drugs, showing a moderate level of detailed engagement with the study's content.

ImpactModerate impact

The focus on clinical cases and potential therapeutic benefits suggests these discussions recognize a meaningful impact in the ongoing search for effective COVID-19 treatments.

Abstract in brief

  • The study reports on four COVID-19 pneumonia patients treated with a combination of Chinese and Western medicines, including antivirals like lopinavir/ritonavir and arbidol, along with traditional Chinese medicine (SFJDC), showing varying levels of clinical improvement.
  • Three patients with mild symptoms showed significant recovery and were discharged, with two testing negative for the virus; one patient with severe pneumonia also showed signs of improvement.
  • The findings suggest that this combined treatment approach might be beneficial, but further research is needed to confirm the effectiveness of the antivirals and traditional medicine used.]

Top posts

Most liked on X and Bluesky
Cedric Dark, MD, MPH, FACEP
@RealCedricDark · X

There's actually some human data on lopinavir/ritonavir for #coronavirus A case study where all 4 patients received the combo, 2 discharged home and 2 still in the hospital. But it's a case series. What would have happened without the drug? https://t.co/rq4saAE4uf

Mar 24, 2020 · 9,395 followers View post →
PubMed Trending
@PubTrend · X

Trending on PubMed: Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. https://t.co/8pk2hcCetM

Feb 13, 2020 · 5,155 followers View post →
DrRPalmquist
@DrPalmquist · X

Clinical Characteristics and Therapeutic Procedure for Four Cases With 2019 Novel Coronavirus Pneumonia Receiving Combined Chinese and Western Medicine Treatment - PubMed https://t.co/ZwL9JWzdcY

Mar 29, 2020 · 3,158 followers View post →
Eiji Sasahara 笹原英司 (he/his)
@esasahara · X

Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medi... - PubMed - NCBI https://t.co/SpvDn1PlZH

Mar 13, 2020 · 858 followers View post →
Researchphilia
@researchphilia · X

Feb 13, 2020 · 485 followers View post →
Researchphilia
@researchphilia · X

Feb 12, 2020 · 485 followers View post →

All mentions

COVID19 Clinical Trials & Research: Covidmune.com
@CovidMune · X

The #chinese medicine Shufeng Jiedu Capsule (SFJDC) appears to have some activity against #covid19 in combination with lopinavir/ritonavir (Kaletra®), and Russian antiviral arbidol #coronavirus #covidmune https://t.co/kL6taFsrNN

Apr 14, 2020 · 366 followers View post →
DrRPalmquist
@DrPalmquist · X

Clinical Characteristics and Therapeutic Procedure for Four Cases With 2019 Novel Coronavirus Pneumonia Receiving Combined Chinese and Western Medicine Treatment - PubMed https://t.co/ZwL9JWzdcY

Mar 29, 2020 · 3,158 followers View post →
Cedric Dark, MD, MPH, FACEP
@RealCedricDark · X

There's actually some human data on lopinavir/ritonavir for #coronavirus A case study where all 4 patients received the combo, 2 discharged home and 2 still in the hospital. But it's a case series. What would have happened without the drug? https://t.co/rq4saAE4uf

Mar 24, 2020 · 9,395 followers View post →
Eiji Sasahara 笹原英司 (he/his)
@esasahara · X

Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medi... - PubMed - NCBI https://t.co/SpvDn1PlZH

Mar 13, 2020 · 858 followers View post →
PubMed Trending
@PubTrend · X

Trending on PubMed: Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. https://t.co/8pk2hcCetM

Feb 13, 2020 · 5,155 followers View post →
Researchphilia
@researchphilia · X

Feb 13, 2020 · 485 followers View post →
Researchphilia
@researchphilia · X

Feb 12, 2020 · 485 followers View post →
the paper link
@the_paper_link · X

Trend new: *Wang Z* et al (Biosci Trends) __Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment__ https://t.co/KBiWsiIDgO

Feb 12, 2020 · 136 followers View post →
NFTdose
@PaperbirdsH · X

New article: Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. https://t.co/OqhnKsF9Jg #coronavirus #wuhan #2019ncov

Feb 11, 2020 · 302 followers View post →